← Back to Search

Cycling to Prevent Colorectal Cancer in Lynch Syndrome Participants

N/A
Waitlist Available
Led By Eduardo Vilar-Sanchez, BLS,MD,PHD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights

Study Summary

This trial studies how well cycling works in preventing colorectal cancer in participants with Lynch syndrome.

Who is the study for?
This trial is for people with Lynch syndrome who are at least 6 months clear of cancer treatments, have some colon or rectum intact, and can sign consent. They must not have active cancer, be able to cycle, and pass a heart-lung exercise test. Excluded are those unable to cycle due to health issues or lack of local classes, recent smokers, or those with certain cardiovascular diseases.Check my eligibility
What is being tested?
The study investigates if cycling can prevent colorectal cancer in individuals with Lynch syndrome. Participants will engage in regular cycling exercises and receive informational interventions while their health is monitored using questionnaires and devices.See study design
What are the potential side effects?
While the trial focuses on exercise which typically has benefits like improved fitness and mood, potential side effects may include muscle soreness, fatigue from physical activity, risk of falls or injuries related to cycling.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence rate
Recruitment rate
Retention

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group I (FITBIT, cycling)Experimental Treatment3 Interventions
Starting on day 15, participants wear FITBIT and complete cycling classes over 45 minutes 3 times a week for a total of 12 classes a month for up to 1 year.
Group II: Group II (FITBIT, information)Active Control3 Interventions
Starting on day 15, participants receive information about exercise guidelines and wear FITBIT to track heart rate and activities for up to 1 year.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Monitoring Device
2018
Completed Phase 2
~2380
Exercise Intervention
2016
Completed Phase 4
~1330

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,646 Total Patients Enrolled
M.D. Anderson Cancer CenterLead Sponsor
2,967 Previous Clinical Trials
1,804,781 Total Patients Enrolled
Eduardo Vilar-Sanchez, BLS,MD,PHDPrincipal InvestigatorM.D. Anderson Cancer Center

Media Library

Cycling 2023 Treatment Timeline for Medical Study. Trial Name: NCT03495674 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals currently being enrolled for this experiment?

"As per the information provided on clinicaltrials.gov, this healthcare study is not recruiting at present. This trial was first posted to the site on April 4th 2018 and last updated July 11th 2022. Despite this, there are currently 1429 other medical trials actively seeking patients for enrolment."

Answered by AI

Am I eligible to participate in this research endeavor?

"Eligibility for this trial requires applicants to be between 18 and 50 years of age, with high-frequency microsatellite instability. The team overseeing the study is aiming to recruit 21 volunteers in total."

Answered by AI

Is the elderly population eligible for enrollment in this research project?

"To participate in this investigation, applicants must be 18 years of age or above and under 50."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Cycling in Preventing Colorectal Cancer in Participants With Lynch Syndrome
2018. "Cycling in Preventing Colorectal Cancer in Participants With Lynch Syndrome". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03495674.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top